Minimize Uncertainty – Make Informed Decisions – Succeed

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Imugene onCARlytics Carteyva collaboration

November 29, 2025clinical trials,Regulatory,Cell Therapy,solid tumours,biopharma,China,immuno-oncology,Lucid Diligence Brief,payer access,diligenceoncolytic virus

Lucid Diligence Brief: Imugene onCARlytics Carteyva collaboration Professional…

by Timos Papagatsias

Respiratory

Respiratory Video Recap—November 28, 2025

November 28, 2025COPD Foundation,Partners Health Management,cystic fibrosis,Flagship Pioneering,gsk,ProFound Therapeutics,Asthma,Quotient Therapeutics,BioPharma and Tech News,BiomX,Bronchiectasis,Qilu Pharmaceutical,tuberculosis,Metabolic dysfunction associated steatohepatitis,Idiopathic Pulmonary Fibrosis,Bacterial lung infection,pulmonary arterial hypertension,Respiratory News,chronic obstructive pulmonary disease,Insmed,TB AllianceInhibikase Therapeutics,Cipla USA

This respiratory video recap covers regulatory approvals, pediatric safety…

by LucidQuest

Vaccines_News

Vaccines Video Recap—November 28, 2025

November 28, 2025CanSino,Blue Lake Biotechnology,multiple sclerosis,pfizer,Moderna,BioPharma and Tech News,tuberculosis,Lyme Disease,Valneva,Small Cell Lung Cancer,Vaccine news,Respiratory syncytial virus infection,Cidara Therapeutics,FluzoneFKUI,Etana

This biweekly Vaccines video recap highlights  late-stage vaccine efficacy,…

by LucidQuest

Public_Health

Public Health Today—28 November, 2025

November 28, 2025antimicrobial resistance,BioPharma and Tech News,mRNA Therapy,Tirzepatide,type 2 diabetes,rheumatoid arthritis,GLP-1 Receptor Agonists,Public Health News,severe asthma,multi-cancer screeninggut microbiome,generative AI drug design

Explore this week’s public health highlights, including new developments,…

by LucidQuest

Vaccines

Vaccines Today—November 28, 2025

November 28, 2025BioPharma and Tech News,lung cancertuberculosis,Lyme Disease,Valneva,Vaccine news,Everest Medicines,influenza,malaria,respiratory syncytial virus,Cidara Therapeutics,R21/Matrix-M

This week’s vaccine report covers major developments, pipeline progress, and…

by LucidQuest

Respiratory

Respiratory Today—November 28, 2025

November 28, 2025cystic fibrosis,gsk,COPD,BioPharma and Tech News,phage therapy,Tezepelumab,pulmonary arterial hypertension,Respiratory News,severe asthmaInhibikase Therapeutics,Glenmark Pharmaceuticals

Explore this week’s respiratory highlights, including new developments,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Waker BioScience Series A in CGT

November 28, 2025market access,Regulatory,cell and gene therapy,EMA,FDA guidance,biopharma,Lucid Diligence Brief,diligence,CRO services,CLIA CAPintegration site analysis

Lucid Diligence Brief: Waker BioScience Series A in CGT Professional audiences…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—November 27, 2025

November 27, 2025novartis,BioPharma and Tech News,NHS,BMS,Cell and Gene Therapy News,SR Tiget,Sarepta,AutolusFondazione Telethon,Arrowhead

This biweekly Cell and Gene Therapy video reacap covers major regulatory…

by LucidQuest

Rare Disease news

Rare Disease Today—November 27, 2025

November 27, 2025novartis,BioPharma and Tech News,SMA,EMD Serono,Rare Disease News,Applied Therapeutics,generalized myasthenia gravis,CLN3 Batten disease,galactosemia,Itvismacladribine capsules,newborn genomic screening

This week’s rare diseases update spotlights key developments, regulatory…

by LucidQuest

Cardiovascular

Cardiovascular Today—November 27, 2025

November 27, 2025BioPharma and Tech News,HEART FAILURETirzepatide,pulmonary hypertension,Philips,Edwards Lifesciences,Evolocumab,Cardiovascular News,mitral TEER,Atherosclerotic cardiovascular disease,TCT,ESC Digital & AI Summit

Stay informed with this week’s cardiology roundup, featuring key advancements,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Phrontline Biopharma $60m Pre-A+

November 27, 2025Oncology,clinical trials,market access,biopharma,CMC,Lucid Diligence Brief,payer access,diligence,venture financing,competitive landscape,antibody-drug conjugates,partnershipsChina biotech

Lucid Diligence Brief: Phrontline Biopharma $60m Pre-A+ Professional audiences…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Sword Health partners with Greece on AI health "front door"

November 26, 2025digital health,Europe,market access,Regulatory,AI in healthcare,public health,biopharma,Lucid Diligence Brief,payer access,diligence,contact centertriage

Lucid Diligence Brief: Sword Health partners with Greece on AI health "front…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.